757 related articles for article (PubMed ID: 30852132)
1. Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial.
Lean MEJ; Leslie WS; Barnes AC; Brosnahan N; Thom G; McCombie L; Peters C; Zhyzhneuskaya S; Al-Mrabeh A; Hollingsworth KG; Rodrigues AM; Rehackova L; Adamson AJ; Sniehotta FF; Mathers JC; Ross HM; McIlvenna Y; Welsh P; Kean S; Ford I; McConnachie A; Messow CM; Sattar N; Taylor R
Lancet Diabetes Endocrinol; 2019 May; 7(5):344-355. PubMed ID: 30852132
[TBL] [Abstract][Full Text] [Related]
2. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial.
Lean ME; Leslie WS; Barnes AC; Brosnahan N; Thom G; McCombie L; Peters C; Zhyzhneuskaya S; Al-Mrabeh A; Hollingsworth KG; Rodrigues AM; Rehackova L; Adamson AJ; Sniehotta FF; Mathers JC; Ross HM; McIlvenna Y; Stefanetti R; Trenell M; Welsh P; Kean S; Ford I; McConnachie A; Sattar N; Taylor R
Lancet; 2018 Feb; 391(10120):541-551. PubMed ID: 29221645
[TBL] [Abstract][Full Text] [Related]
3. 5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study.
Lean ME; Leslie WS; Barnes AC; Brosnahan N; Thom G; McCombie L; Kelly T; Irvine K; Peters C; Zhyzhneuskaya S; Hollingsworth KG; Adamson AJ; Sniehotta FF; Mathers JC; McIlvenna Y; Welsh P; McConnachie A; McIntosh A; Sattar N; Taylor R
Lancet Diabetes Endocrinol; 2024 Apr; 12(4):233-246. PubMed ID: 38423026
[TBL] [Abstract][Full Text] [Related]
4. Effect of intensive lifestyle intervention on bodyweight and glycaemia in early type 2 diabetes (DIADEM-I): an open-label, parallel-group, randomised controlled trial.
Taheri S; Zaghloul H; Chagoury O; Elhadad S; Ahmed SH; El Khatib N; Amona RA; El Nahas K; Suleiman N; Alnaama A; Al-Hamaq A; Charlson M; Wells MT; Al-Abdulla S; Abou-Samra AB
Lancet Diabetes Endocrinol; 2020 Jun; 8(6):477-489. PubMed ID: 32445735
[TBL] [Abstract][Full Text] [Related]
5. The Diabetes Remission Clinical Trial (DiRECT): protocol for a cluster randomised trial.
Leslie WS; Ford I; Sattar N; Hollingsworth KG; Adamson A; Sniehotta FF; McCombie L; Brosnahan N; Ross H; Mathers JC; Peters C; Thom G; Barnes A; Kean S; McIlvenna Y; Rodrigues A; Rehackova L; Zhyzhneuskaya S; Taylor R; Lean ME
BMC Fam Pract; 2016 Feb; 17():20. PubMed ID: 26879684
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of weight loss-induced remission in people with prediabetes: a post-hoc analysis of the randomised, controlled, multicentre Prediabetes Lifestyle Intervention Study (PLIS).
Sandforth A; von Schwartzenberg RJ; Arreola EV; Hanson RL; Sancar G; Katzenstein S; Lange K; Preißl H; Dreher SI; Weigert C; Wagner R; Kantartzis K; Machann J; Schick F; Lehmann R; Peter A; Katsouli N; Ntziachristos V; Dannecker C; Fritsche L; Perakakis N; Heni M; Nawroth PP; Kopf S; Pfeiffer AFH; Kabisch S; Stumvoll M; Schwarz PEH; Hauner H; Lechner A; Seissler J; Yurchenko I; Icks A; Solimena M; Häring HU; Szendroedi J; Schürmann A; de Angelis MH; Blüher M; Roden M; Bornstein SR; Stefan N; Fritsche A; Birkenfeld AL
Lancet Diabetes Endocrinol; 2023 Nov; 11(11):798-810. PubMed ID: 37769677
[TBL] [Abstract][Full Text] [Related]
7. Tackling obesity in areas of high social deprivation: clinical effectiveness and cost-effectiveness of a task-based weight management group programme - a randomised controlled trial and economic evaluation.
McRobbie H; Hajek P; Peerbux S; Kahan BC; Eldridge S; Trépel D; Parrott S; Griffiths C; Snuggs S; Myers Smith K
Health Technol Assess; 2016 Oct; 20(79):1-150. PubMed ID: 27802843
[TBL] [Abstract][Full Text] [Related]
8. Randomised controlled trial and economic analysis of an internet-based weight management programme: POWeR+ (Positive Online Weight Reduction).
Little P; Stuart B; Hobbs FR; Kelly J; Smith ER; Bradbury KJ; Hughes S; Smith PW; Moore MV; Lean ME; Margetts BM; Byrne CD; Griffin S; Davoudianfar M; Hooper J; Yao G; Zhu S; Raftery J; Yardley L
Health Technol Assess; 2017 Jan; 21(4):1-62. PubMed ID: 28122658
[TBL] [Abstract][Full Text] [Related]
9. Clinical and metabolic features of the randomised controlled Diabetes Remission Clinical Trial (DiRECT) cohort.
Taylor R; Leslie WS; Barnes AC; Brosnahan N; Thom G; McCombie L; Sattar N; Welsh P; Peters C; Zhyzhneuskaya S; Hollingsworth KG; Al-Mrabeh A; Rodrigues AM; Rehackova L; Adamson AJ; Sniehotta FF; Mathers JC; Ross HM; McIlvenna Y; Kean S; Ford I; McConnachie A; Lean MEJ
Diabetologia; 2018 Mar; 61(3):589-598. PubMed ID: 29188339
[TBL] [Abstract][Full Text] [Related]
10. Extended and standard duration weight-loss programme referrals for adults in primary care (WRAP): a randomised controlled trial.
Ahern AL; Wheeler GM; Aveyard P; Boyland EJ; Halford JCG; Mander AP; Woolston J; Thomson AM; Tsiountsioura M; Cole D; Mead BR; Irvine L; Turner D; Suhrcke M; Pimpin L; Retat L; Jaccard A; Webber L; Cohn SR; Jebb SA
Lancet; 2017 Jun; 389(10085):2214-2225. PubMed ID: 28478041
[TBL] [Abstract][Full Text] [Related]
11. Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): a pragmatic, open-label, 12-month, randomised controlled trial.
Furler J; O'Neal D; Speight J; Blackberry I; Manski-Nankervis JA; Thuraisingam S; de La Rue K; Ginnivan L; Doyle R; Holmes-Truscott E; Khunti K; Dalziel K; Chiang J; Audehm R; Kennedy M; Clark M; Jenkins A; Lake AJ; Januszewski AS; Catchpool M; Liew D; Clarke P; Best J
Lancet Diabetes Endocrinol; 2020 Jan; 8(1):17-26. PubMed ID: 31862147
[TBL] [Abstract][Full Text] [Related]
12. 2-year remission of type 2 diabetes and pancreas morphology: a post-hoc analysis of the DiRECT open-label, cluster-randomised trial.
Al-Mrabeh A; Hollingsworth KG; Shaw JAM; McConnachie A; Sattar N; Lean MEJ; Taylor R
Lancet Diabetes Endocrinol; 2020 Dec; 8(12):939-948. PubMed ID: 33031736
[TBL] [Abstract][Full Text] [Related]
13. Long-term effects of intensive multifactorial therapy in individuals with screen-detected type 2 diabetes in primary care: 10-year follow-up of the ADDITION-Europe cluster-randomised trial.
Griffin SJ; Rutten GEHM; Khunti K; Witte DR; Lauritzen T; Sharp SJ; Dalsgaard EM; Davies MJ; Irving GJ; Vos RC; Webb DR; Wareham NJ; Sandbæk A
Lancet Diabetes Endocrinol; 2019 Dec; 7(12):925-937. PubMed ID: 31748169
[TBL] [Abstract][Full Text] [Related]
14. Predictors of type 2 diabetes remission in the Diabetes Remission Clinical Trial (DiRECT).
Thom G; Messow CM; Leslie WS; Barnes AC; Brosnahan N; McCombie L; Al-Mrabeh A; Zhyzhneuskaya S; Welsh P; Sattar N; Taylor R; Lean MEJ
Diabet Med; 2021 Aug; 38(8):e14395. PubMed ID: 32870520
[TBL] [Abstract][Full Text] [Related]
15. Extended follow-up of a short total diet replacement programme: results of the Doctor Referral of Overweight People to Low Energy total diet replacement Treatment (DROPLET) randomised controlled trial at 3 years.
Astbury NM; Edwards RM; Ghebretinsea F; Shanyinde M; Mollison J; Aveyard P; Jebb SA
Int J Obes (Lond); 2021 Nov; 45(11):2432-2438. PubMed ID: 34302120
[TBL] [Abstract][Full Text] [Related]
16. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial.
Mingrone G; Panunzi S; De Gaetano A; Guidone C; Iaconelli A; Nanni G; Castagneto M; Bornstein S; Rubino F
Lancet; 2015 Sep; 386(9997):964-73. PubMed ID: 26369473
[TBL] [Abstract][Full Text] [Related]
17. Antihypertensive medication needs and blood pressure control with weight loss in the Diabetes Remission Clinical Trial (DiRECT).
Leslie WS; Ali E; Harris L; Messow CM; Brosnahan NT; Thom G; McCombie EL; Barnes AC; Sattar N; Taylor R; Lean MEJ
Diabetologia; 2021 Sep; 64(9):1927-1938. PubMed ID: 34056684
[TBL] [Abstract][Full Text] [Related]
18. Effects of 3 months of 10-h per-day time-restricted eating and 3 months of follow-up on bodyweight and cardiometabolic health in Danish individuals at high risk of type 2 diabetes: the RESET single-centre, parallel, superiority, open-label, randomised controlled trial.
Quist JS; Pedersen HE; Jensen MM; Clemmensen KKB; Bjerre N; Ekblond TS; Uldal S; Størling J; Wewer Albrechtsen NJ; Holst JJ; Torekov SS; Nyeland ME; Vistisen D; Jørgensen ME; Panda S; Brock C; Finlayson G; Blond MB; Færch K
Lancet Healthy Longev; 2024 May; 5(5):e314-e325. PubMed ID: 38588687
[TBL] [Abstract][Full Text] [Related]
19. Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomised controlled trial.
Cummings DE; Arterburn DE; Westbrook EO; Kuzma JN; Stewart SD; Chan CP; Bock SN; Landers JT; Kratz M; Foster-Schubert KE; Flum DR
Diabetologia; 2016 May; 59(5):945-53. PubMed ID: 26983924
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
